Answers are grounded in this paper and cite their sources.
Review assesses Controlled Attenuation Parameter for diagnosing liver conditions, implying need for contextual interpretation.
This review assesses the utility of the Controlled Attenuation Parameter (CAP) in Autoimmune Liver Diseases (AILD). CAP demonstrates high diagnostic accuracy for hepatic steatosis in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis. However, in Autoimmune Hepatitis, active inflammation can depress CAP values, complicating its interpretation. Therefore, CAP use in AILD requires disease-contextualized understanding.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: